ASTRAZENECA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,928.00 GBX | -1.01% |
|
-5.71% | +12.53% |
| Sep. 13 | AstraZeneca, Daiichi Sankyo Breast Cancer Drug Trial Shows 'Substantial Clinical Activity' | MT |
| Sep. 13 | Daiichi, Astra's Enhertu shows clinical activity in brain metastases | AN |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 20 | |||||||||
| 25 | |||||||||
| 26 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 26 | |||||||||
| 19 | |||||||||
| 20 | |||||||||
| 24 | |||||||||
| 22 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 21 | |||||||||
| 21 | |||||||||
| 15 | |||||||||
| 16 | |||||||||
| 18 | |||||||||
| 17 | |||||||||
| 15 | |||||||||
| Average | 21 | ||||||||
| Weighted average by Cap. | 23 |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector revisions